Drug Trial News

RSS
Researchers test new anti-malaria medication

Researchers test new anti-malaria medication

World’s first vaccine relieves grass pollen allergy symptoms by at least 25%, study shows

World’s first vaccine relieves grass pollen allergy symptoms by at least 25%, study shows

New universal flu vaccine moves to clinical trial phase and could be a reality soon

New universal flu vaccine moves to clinical trial phase and could be a reality soon

ASIT biotech’s new article presents clinical results of gp - ASIT+ for treatment of grass pollen-induced rhinitis

ASIT biotech’s new article presents clinical results of gp - ASIT+ for treatment of grass pollen-induced rhinitis

Generic skin cream may reduce squamous cell carcinoma risk

Generic skin cream may reduce squamous cell carcinoma risk

Nanobiotix receives FDA approval for first immuno-oncology trial

Nanobiotix receives FDA approval for first immuno-oncology trial

Novel drug shows promise in treating metastatic kidney cancer

Novel drug shows promise in treating metastatic kidney cancer

FDA proposes new approach to the regulation of unapproved, potentially harmful homeopathic drugs

FDA proposes new approach to the regulation of unapproved, potentially harmful homeopathic drugs

Porvair and Suzhou Tianlong Bio to develop epigenetic analysis technologies

Porvair and Suzhou Tianlong Bio to develop epigenetic analysis technologies

Groundbreaking gene therapy trial brings cure for hemophilia closer

Groundbreaking gene therapy trial brings cure for hemophilia closer

IPM begins first clinical trial of vaginal rings to prevent HIV in women

IPM begins first clinical trial of vaginal rings to prevent HIV in women

FDA researchers find underrepresentation of adults aged 75 years and older in blood cancer clinical trials

FDA researchers find underrepresentation of adults aged 75 years and older in blood cancer clinical trials

Study: Combination targeted therapy has high response rates in AML patients

Study: Combination targeted therapy has high response rates in AML patients

Butler Hospital launches international Alzheimer's disease prevention study

Butler Hospital launches international Alzheimer's disease prevention study

Pairing immunotherapy drug with chemotherapy proves beneficial for relapsed acute myeloid leukemia

Pairing immunotherapy drug with chemotherapy proves beneficial for relapsed acute myeloid leukemia

Combination of chemotherapy and targeted drug improves response in younger CLL patients

Combination of chemotherapy and targeted drug improves response in younger CLL patients

CAR T cell therapy shows long-lasting remissions in non-Hodgkin's lymphoma patients

CAR T cell therapy shows long-lasting remissions in non-Hodgkin's lymphoma patients

Drug improves disease-free, overall survival after hematopoietic stem cell transplants

Drug improves disease-free, overall survival after hematopoietic stem cell transplants

Novel compound along with checkpoint inhibitors may enhance immune response in melanoma patients

Novel compound along with checkpoint inhibitors may enhance immune response in melanoma patients

PARP inhibitor can be new treatment option for patients with metastatic breast cancer, BRCA mutations

PARP inhibitor can be new treatment option for patients with metastatic breast cancer, BRCA mutations